secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001654954-24-013446
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA Life Sciences stockholders approve reverse stock split; board sets ratio at 1-for-35
--------------------------------------------------------------------------------

- Stockholders approved reverse stock split at Special Meeting on Oct 28, 2024 with 4,241,540 for, 2,792,189 against, 18,228 abstain.
- Board of Directors subsequently approved a ratio of 1-for-35 for the reverse stock split.
- Reverse split ratio may be implemented at board's discretion within one year of meeting date; all other proposed ratios abandoned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495424013446/0001654954-24-013446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495424013446/endra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-013446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer